Jeff Fensterer - Accustem Sciences Chief Officer

All Insiders . USA . 
Stock . Accustem Sciences . Stakeholders . Insider . Jeff Fensterer
ACUT Stock  USD 0.24  0.00  0.00%   

Insider

Jeff Fensterer is Chief Officer of Accustem Sciences
Age 44
Webhttps://www.accustem.com

Similar Executives

Showing other executives

INSIDER Age

LLB JDAntibe Therapeutics
65
Annie LeeOpthea
N/A
Matthew GallIteos Therapeutics
47
Ian LeitchOpthea
61
Badreddin EdrisEdgewise Therapeutics
37
Philip SternAntibe Therapeutics
N/A
Andreas EMBAMolecular Partners AG
58
Michael CarruthersEdgewise Therapeutics
66
Alexander ZurcherMolecular Partners AG
49
Yvonne McGrathIteos Therapeutics
50
Thomas SchwerzmannMolecular Partners AG
N/A
Michael PitznerMolecular Partners AG
N/A
Alan RussellEdgewise Therapeutics
54
James GodingOpthea
N/A
MBA MScAntibe Therapeutics
65
MBA MBAAntibe Therapeutics
N/A
Seth LewisMolecular Partners AG
N/A
Patrick AmstutzMolecular Partners AG
49
MAICD MAICDOpthea
48
Ryan BakerIteos Therapeutics
N/A
Ana StegicAntibe Therapeutics
N/A
AccuStem Sciences, Inc. operates as a life sciences company focusing on improving outcomes for patients with cancer. It develops StemPrintER technology, a multi-gene prognostic assay to predict the risk of recurrence of Endocrine receptor-positive HER2- breast cancer and Spare, a derivative of StemPrintER that combines StemPrintER with two clinical markers. Accustem Sciences is traded on OTC Exchange in the United States. Accustem Sciences [ACUT] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Accustem Sciences Management Team

Elected by the shareholders, the Accustem Sciences' board of directors comprises two types of representatives: Accustem Sciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Accustem. The board's role is to monitor Accustem Sciences' management team and ensure that shareholders' interests are well served. Accustem Sciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Accustem Sciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
Jeff Fensterer, Chief Officer
Joe Flanagan, Chief Officer
Wendy Blosser, CEO Director

Accustem Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Accustem Sciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Shares Owned By Insiders45.00 %

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Accustem OTC Stock Analysis

When running Accustem Sciences' price analysis, check to measure Accustem Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accustem Sciences is operating at the current time. Most of Accustem Sciences' value examination focuses on studying past and present price action to predict the probability of Accustem Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accustem Sciences' price. Additionally, you may evaluate how the addition of Accustem Sciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY